Freeline Evaluating Options After No Home Run For Hem B Gene Therapy

At Crossroads As Rivals Advance

 
• By Andrew McConaghie

Freeline’s FLT180a could still prove to be the best-in-class gene therapy for hemophilia B but its cash and time are running out as rivals grow closer to market.

Factor IX
All three patients saw their Factor IX levels rise to normal levels - but these fell back in two patients after the trial cut-off period. • Source: Shutterstock

More from Blood and Clotting

More from Therapy Areas